20 WORLD GASTROENTEROLOGY NEWS MAY 2016 Editorial | Expert Point of View | Gastro 2016: EGHS-WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events Presented by: Raj Reddy, MD University of Pennsylvania VISIT WWW.IC-HEP.COM THE GROWING PREVALENCE OF HEPATITIS C (HCV) IS A GLOBAL CONCERN. HCV affects more than 185 million persons throughout the world. If left untreated, HCV can result in irreversible clinical consequences, such as liver cirrhosis or hepatocellular carcinoma, and can even lead to death. Fortunately, with proper detection and treatment, HCV can be cured in more than 90% of patients. However, many patients remain undiagnosed, are not treated properly, or do not have access to treatment. In April 2014 the World Health Organization (WHO) produced their first guidelines dealing with HCV that consist of nine key recommendations. Implementation of the new WHO guidelines for HCV can assist in the following: SCREENING: Identifying patients with HCV and confirming the diagnosis CARE: Assessing the degree of liver damage and reducing progression TREATMENT: Choosing the best treatment based on what drugs are regionally available The guidelines also take into account that global availability of options for screening, care, and treatment vary. This webcast entitled “Review of the WHO Guidelines for the Screening, Care, and Treatment of Persons with HCV” is intended for healthcare professionals who care for patients with HCV. The goal is to examine the WHO guidelines for HCV and discuss the global implications of these guidelines. In addition, information on prevalence, natural history, clinical consequences, and treatment will be discussed. Accredited by: This activity is supported by educational grants from AbbVie, Endorsed by: Bristol-Myers Squibb, Gilead Sciences, Inc., and Merck. ACCREDITATION STATEMENTS & CREDIT DESIGNATION - This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and International Coalition of Hepatology Education Providers (IC-HEP). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians. The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity. THROUGH AN EDUCATIONAL COLLABORATION WITH THE WGO, THE INTERNATIONAL COALITION OF HEPATOLOGY EDUCATION PROVIDERS (IC-HEP) IS PLEASED TO PRESENT: REVIEW OF THE WHO GUIDELINES FOR THE SCREENING, CARE, AND TREATMENT OF PERSONS WITH HCV View CME Webcast Learn about WGO Educational Programs Providing high quality educational opportunities for all levels of resources. www.worldgastroenterology.org
ewgn-vol21-issue1-FINAL
To see the actual publication please follow the link above